ZGGS18 for Advanced Solid Tumors
Study of ZGGS18 in Patients With Advanced Solid Tumors
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 222 (estimated)
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Industry
This trial is looking for patients with advanced solid tumors who have not responded to standard treatments. Participants will receive a treatment called ZGGS18 to evaluate how well it works and its safety.
You may be able to join if
- I have advanced solid tumors confirmed by medical tests.
- I have not responded to standard treatments or cannot tolerate them.
- I have a performance status of 0 or 1.
- I expect to live for at least 3 more months.
- I have at least 1 measurable tumor lesion.
- My measurable lesions are not from radiation therapy or have progressed after such therapy.
You may not be able to join if
- My doctor feels I am not suitable for this trial.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityA clinical study to assess dose escalation, tolerance, safety, pharmacokinetics, and multi cohort expansion of ZGGS18 in patients with advanced solid tumors
Loading trial locations…